Thomas Wurdinger PhD

Thomas Wurdinger obtained his Ph.D. in virology and gene therapy at Utrecht University, Utrecht, The Netherlands. After that he moved to Boston, the USA to start his postdoc period as a research fellow at Massachusetts General Hospital and Harvard Medical School under the guidance of Prof. dr. X.O. Breakefield and Prof. dr. R. Weissleder. He has a position as a professor at VU University Medical Center and Cancer Center Amsterdam, The Netherlands. He is the co-founder of thromboDx BV and Exbiome BV.